XRAY vs BLFS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 19, 2026
XRAY
BLFS
Investment Advisor Scores
BLFS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XRAY | BLFS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.728 | 303.0303 | XRAY |
| PEG Ratio | 0.7727 | 65.3833 | XRAY |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.1% | 21.5% | BLFS |
| Earnings Growth | 15.2% | -13.9% | XRAY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.2/100 | 35.7/100 | XRAY |
| Profit Margin | -15.0% | 54.4% | BLFS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XRAY
NeutralMixed signals - no dominant trend phase, RSI 36
BLFS
MarkupPrice above SMA50, rising 50-day trend (13.8% over 20 days), RSI 78
Fundamentals Snapshot
| Metric | XRAY | BLFS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.2 | 112.4 |
| Trailing P/E | — | 37.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.2% |
| Gross Margin | 0.5% | 0.6% |
| Operating Margin | 0.1% | 0.1% |
| EPS | -2.71 | 1.00 |
| Dividend Yield | 0.03% | — |